MPPE1 and neoplasm: Although these experimental settings could alter cDC1 and lymphoid cell trafficking (83, 84), they nevertheless show that the activation of antitumor adaptive immunity can occur directly at the tumor site (82), possibly in tertiary lymphoid structures developing locally (85).